Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting fees and expenses.
Offering to close on August 15, 2025, subject to customary closing conditions, with Maxim Group LLC as the sole placement agent.
Offer Details
3,225,000 shares of common stock to be sold at $1.20 per share.
Gross Proceeds
Expected gross proceeds of approximately $3.9 million before deductions.
Closing Date
Offering expected to close on August 15, 2025.
- The offering is being made through a registered direct offering.
- Maxim Group LLC is the sole placement agent for the offering.
Scienture Holdings, Inc.'s entrance into the securities purchase agreement signifies a significant step towards raising capital for its operations and future endeavors in the pharmaceutical industry.